Is Ciprofloxacin a Substrate of P-glycoprotein?

Archives of Drug Information

Volumn 4, Issue 1, 2011, Pages 1-9

  Park, Miki Susanto ^a   Okochi, Hideaki ^b   Benet, Leslie Z ^b  

^a UNIVERSITY OF THE PACIFIC   (United States)

^b San Francisco   (United States)

Author keywords

Ciprofloxacin; MRP1; MRP2; P glycoprotein

Indexed keywords

CIPROFLOXACIN; CYCLOSPORIN; DICLOXACILLIN; ELACRIDAR; ERYTHROMYCIN; GLYCOPROTEIN P; GLYCOSARCOSINE; INDOMETACIN; KETOCONAZOLE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; PROBENECID; QUINIDINE; SARCOSINE; SULFINPYRAZONE; TRIMETHOPRIM; UNCLASSIFIED DRUG; VERAPAMIL; VINBLASTINE;

ARTICLE; DRUG TRANSPORT; GENE EXPRESSION; INTRACELLULAR TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 79951776566     PISSN: None     EISSN: 17535174     Source Type: Journal    
DOI: 10.1111/j.1753-5174.2010.00032.x     Document Type: Article

References (17)

1. Eliopoulos GM, Gardella A, Moellering RC Jr. In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent. Antimicrob Agents Chemother 1984;25:331-5.
2. Sorgel F, Naber KG, Jaehde U, Reiter A, Seelmann R, Sigl G. Gastrointestinal secretion of ciprofloxacin. Evaluation of the charcoal model for investigations in healthy volunteers. Am J Med 1989;87:62S-5S.
3. Rohwedder R, Bergan T, Thorsteinsson SB, Scholl H. Transintestinal elimination of ciprofloxacin. Chemotherapy 1990;36:77-84.
4. Parry MF, Smego DA, Digiovanni MA. Hepatobiliary kinetics and excretion of ciprofloxacin. Antimicrob Agents Chemother 1988;32:982-5.
5. Cavet ME, West M, Simmons NL. Fluoroquinolone (ciprofloxacin) secretion by human intestinal epithelial (Caco-2) cells. Br J Pharmacol 1997;121:1567-78.
6. Dautrey S, Felice K, Petiet A, Lacour B, Carbon C, Farinotti R. Active intestinal elimination of ciprofloxacin in rats: Modulation by different substrates. Br J Pharmacol 1999;127:1728-34.
7. de Lange EC, Marchand S, van den Berg D, van der Sandt IC, de Boer AG, Delon A, etal. In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin. Eur J Pharm Sci 2000;12:85-93.
8. Griffiths NM, Hirst BH, Simmons NL. Active secretion of the fluoroquinolone ciprofloxacin by human intestinal epithelial Caco-2 cell layers. Br J Pharmacol 1993;108:575-6.
9. Lowes S, Simmons NL. Multiple pathways for fluoroquinolone secretion by human intestinal epithelial (Caco-2) cells. Br J Pharmacol 2002;135:1263-75.
10. Pastan I, Gottesman MM, Ueda K, Lovelace E, Rutherford AV, Willingham MC. A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc Natl Acad Sci U S A 1988;85:4486-90.
11. Evers R, Zaman GJ, van Deemter L, Jansen H, Calafat J, Oomen LC, etal. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. J Clin Invest 1996;97:1211-8.
12. Susanto M. Investigating the role of P-glycoprotein on drugs exhibiting enhanced renal clearance in cystic fibrosis patients. Thesis (Ph.D.), University of California San Francisco, San Francisco, CA2002.
13. Susanto M, Benet LZ. Can the enhanced renal clearance of antibiotics in cystic fibrosis patients be explained by P-glycoprotein transport? Pharm Res 2002;19:457-62.
14. Zhang Y, Benet LZ. Characterization of P-glycoprotein mediated transport of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor, across MDR1-MDCK and Caco-2 cell monolayers. Pharm Res 1998;15:1520-4.
15. Vanwert AL, Srimaroeng C, Sweet DH. Organic anion transporter 3 (oat3/slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacin. Mol Pharmacol 2008;74:122-31.
16. Landersdorfer CB, Kirkpatrick CM, Kinzig M, Bulitta JB, Holzgrabe U, Jaehde U, etal. Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid. Br J Clin Pharmacol 2010;69:167-78.
17. Yamazaki M, Neway WE, Ohe T, Chen I, Rowe JF, Hochman JH, etal. In vitro substrate identification studies for P-glycoprotein-mediated transport: Species difference and predictability of in vivo results. J Pharmacol Exp Ther 2001;296:723-35.